Our Subsidiaries

Growth by Strategy

We are on a mission to build a healthier planet, and to achieve this goal, we are committed to fostering new partnerships and strategic acquisitions that will help us fast-track our pace, ensure we gain the right domain expertise, and establish a global footprint to deliver world-class solutions across the pharma life cycle.

Mayank Singhal

Our Subsidiaries

arcihimca 1 1

Archimica S.p.A

The acquisition of Archimica S.p.A. enhances our pharmaceutical solutions, strengthening CDMO capabilities, expanding API manufacturing, and opening new global markets. Their compliance and quality standards align with our commitment to excellence. We welcome Archimica S.p.A. for future innovation. As Archimica, Lodi-Milan, since 1947, our Italian facility serves 200+ customers, with 24 DMFs and 4 CEPs. USFDA and AIFA approvals ensure compliance. Our expert team specializes in custom manufacturing, offering a wide range of APIs and pharmaceutical intermediates, supporting clinical trials from Phase I to III.